Early Access to Medicines Scheme Archives -

The UK regulator has said eligible patients with prostate cancer will get early access to a radioligand therapy

UK grants early access to Novartis’ prostate cancer radioligand

https://pharmaphorum.com/news/uk-grants-early-access-to-novartis-prostate-cancer-radioligand/

The UK drugs regulator has backed Merck KGaA’s MET inhibitor for the treatment of some patients with non-small

Merck’s targeted lung cancer drug tepotinib wins early access in UK

https://pharmaphorum.com/news/mercks-targeted-lung-cancer-drug-tepotinib-wins-early-access-in-uk/

Boehringer Ingelheim is the latest company to gain a Promising Innovative Medicine (PIM) status in the UK for

BI drug named Promising Innovative Medicine in mesothelioma

https://pharmaphorum.com/news/bi-drug-named-promising-innovative-medicine-mesothelioma/

Patients to get Santhera’s Raxone under EAMS scheme.

UK patients gain early access to Duchenne drug

https://pharmaphorum.com/news/uk-patients-get-early-access-duchenne-drug/

Early Access to Medicines Scheme